Amy Wakeham | VP, IR & Corporate Communications |
Mick Farrell | CEO |
Brett Sandercock | CFO |
Rob Douglas | President and COO |
Jim Hollingshead | President, Sleep & Respiratory Care business |
David Pendarvis | Chief Administrative Officer and Global General Counsel |
David Low | JPMorgan |
Gretel Janu | Credit Suisse |
Lyanne Harrison | Bank of America |
Saul Hadassin | Barrenjoey |
Dan Hurren | MST |
Matthew Mishan | KeyBanc |
David Bailey | Macquarie |
Mike Matson | Needham & Company |
Suraj Kalia | Oppenheimer |
Hello and welcome to the Q3 Fiscal Year 2022 ResMed Earnings Conference Call. My name is Kevin and I’ll be your operator for today’s call. At this time, all participants are in listen-only mode. Later we’ll conduct a question-and-answer session. Please note that this conference is being recorded.